SLU-PP-332: ERR Exercise-Mimetic Research Map (Not an FDA Pill)

Verdict up front: SLU-PP-332 is worth understanding if you keep seeing “exercise in a pill,” ERR on-switch, ShredMAX, or Saint Louis University exercise-copy headlines. It is not worth treating a preclinical chemical tool like a Wegovy stand-in. It is not a Zone 2 replacement. This free page will not hand you a fat-loss dose chart.

Real ACS and JPET papers. Real ERRα-weighted pan-agonism. Real partner research SKUs that put SLU-PP-332 on a label. Zero honest path from “I bought a capsule bottle” to “I ran a metabolic drug protocol from social media.”

Keep reading if you typed SLU-PP-332, ShredMAX, exercise-copy signal, ERR on-switch, or “is this just another research fat burner” and want the map without guru noise. Skip if you want a public dose chart. Skip if you want a claim that a research bottle treats obesity, type 2 diabetes, heart failure, kidney disease, or sarcopenia. Skip if you want a reason to skip Zone 2, protein, sleep, and doctor care. Those asks belong in Pro or a real clinic — not a free ranking page.

Day-one basics still live on Start Here and what are peptides. Nearby maps when you finish here: MOTS-c, 5-Amino-1MQ, AOD-9604, Tesamorelin, NAD+, peptides for weight loss, Zone 2 training, how to sleep better, and protein intake.

Teaching only. Not medical advice. A research shelf SLU-PP-332 product is not an FDA-approved drug for obesity, diabetes, heart failure, kidney disease, sarcopenia, or “cardio in a bottle.” It is not a green light to skip a doctor. When people oversell “just the exercise-copy signal.”

What is SLU?

Start with the plain name. SLU is a lab-made small molecule. It turns on the estrogen-related receptors — ERRα, ERRβ, and ERRγ. It hits all three. The strongest punch is toward ERRα in the published chemistry work.

Those ERR proteins are nuclear receptors. Translation: they sit in the cell’s control room and help decide which metabolic genes get turned up. They are called “estrogen-related” because of family resemblance. They are not the classical estrogen receptors you hear about in HRT talk.

Partner shelves put SLU on research capsules. BioLongevity’s ShredMAX line is one public tracked home for that molecule. Limitless also lists a named SLU capsule SKU. Same research neighborhood. Different bottle art.

It is not MOTS-c. It is not 5-Amino-1MQ. It is not AOD-9604. Same social aisle as other “metabolic research” products. Different target. Different evidence stack.

People mash “exercise-copy signal” with clinic GLP-1 marketing and forum fat-burner stacks. Your mitochondria do not care about the nickname. They care whether you can separate a chemical-tool paper from a shelf SKU and from real metabolic care.

Why this matters: forums treat SLU like one fat-loss drug with one protocol. It is a pan-ERR research agonist. The evidence lane is short and mostly rodent.

So what for you: if a sales page never says ERR or estrogen-related receptor out loud, it is selling vibes.

The gym-stereo analogy (one mechanism picture)

Here is the only picture I want stuck in your head.

Think of your mitochondria as a gym stereo system. The three big knobs on the board are labeled ERRα, ERRβ, and ERRγ. When you actually train — especially aerobic work — your body turns those knobs together. Fat burning goes up. Endurance-fiber programs get louder. Cellular breathing improves.

SLU is sold and studied as a remote control for that board. In cell and mouse work, it presses play on an aerobic exercise gene program. ERRα does a lot of the heavy lifting. That is the mechanism claim. It is not “this capsule is a marathon.”

How sure are we? Pretty sure SLU is a real named pan-ERR on-switch in published chemistry papers. Pretty sure researchers watched it raise mitochondrial function in muscle cells. Pretty sure it shifted mouse muscle toward more oxidative type IIa fibers with better treadmill endurance. Pretty sure follow-on work tied ERR turn-on to metabolic-syndrome model gains. Less sure every Instagram “cardio stack” matches those lab setups. Not sure at all that a research bottle replaces Zone 2, protein, sleep, or an endocrinologist when something is actually wrong.

Why this matters: if you cannot explain “remote vs real workout vs clinic drug” in one sentence, you are not ready to open a cart.

So what for you: ask for the ERR story before you ask for a price.

The stop-you number (and what it is not)

The cleanest “this pathway is not a cartoon” line on the SLU side is not a forum screenshot. It is a stubborn naming fact plus a confidence dial.

In 2023, Billon and colleagues published in ACS Chemical Biology. They showed SLU raised mitochondrial function in a muscle cell line. SLU is a lab-made ERR pan-agonist with highest punch for ERRα. It increased type IIa oxidative fibers in mice. It also boosted exercise endurance. ERRα turn-on was critical for that endurance bump.

Say that out loud. A named SLU signal turning up an aerobic program in mice. Not a US drug label for your waistline.

Related 2024 work in the Journal of Pharmacology and Experimental Therapeutics pushed the same agonist into diet-induced obese and ob/ob mouse models. Energy burn went up. Fatty-acid use went up. Fat-mass gain went down. Insulin sensitivity improved in those models. Interesting neighborhood. Still not your research bottle as an FDA obesity plan.

Real published SLU / ERR on-switch work. Mostly cell and mouse tiers. Not a US drug label on a research bottle.

Why this matters: the stop-you detail is that SLU is a named object in the ERR exercise-copy literature. The confidence for “my SLU capsule is just DIY cardio medicine” is still zero.

So what for you: be impressed by the ERR map. Do not confuse a chemical tool with a prescription pad.

Evidence limits (say this out loud)

Most SLU teaching still rests on chemistry papers, muscle-cell breathing lab tests, and mouse exercise studies. It also rests on metabolic-syndrome rodent models and neighboring ERR work on kidney, heart, and muscle aging. There is no published path that turns a research SLU bottle into an FDA-approved obesity, diabetes, heart-failure, or sarcopenia drug.

That does not make the science fake. It makes the confidence level clear. Cell and animal screens are useful. They are not your calorie plan. They are not your A1c plan. They are not your cardiac rehab plan.

Also hold the shelf-vs-paper gap. Social media sells “exercise in a pill.” PubMed studies a pan-ERR chemical tool that can turn on pieces of an aerobic gene program in mice. Same molecule idea. Different sales story. Honesty needs both sentences.

Anti-doping and lab papers are already sniffing around SLU and related ERR on-switchs as potential misuse agents. That is a sports-integrity signal. Not a green light for DIY use.

Why this matters: health pages get punished when they blur “interesting research chemical” into “treat yourself.”

So what for you: if someone has uncontrolled diabetes, chest pain on exertion, odd weight loss, or kidney failure symptoms, this page is not the tool. Get human help.

Research SKU vs doctor care vs basics

Three doors. Same metabolic curiosity online. Different jobs.

Door 1 — Research shelf SLU. Partner shelves can list SLU or ShredMAX as a research SKU. That is a convenience and a certificate story. It is not FDA-approved metabolic medicine. It is not a pharmacy-mixed Rx by default.

Door 2 — Doctor metabolic care. Real obesity, diabetes, fatty liver, heart failure, kidney disease, and sarcopenia workups belong with a doctor. That person can run labs. They can discuss approved options. They can watch side effects. An ERR research map does not replace that door. Clinic-lane maps like GLP-1 education still belong under doctor framing, not forum.

Door 3 — Basics. Zone 2 that you can actually sustain. Protein that covers the basics. Sleep that recovers. Body-weight habits that matter long before a hype bottle. See Zone 2 training, protein intake, how to sleep better, and VO2 max.

Why this matters: most money gets wasted when people buy Door 1. While wanting Door 2 outcomes and skipping Door 3.

So what for you: pick the door that matches your actual question before you open a cart.

SLU vs MOTS-c / 5-Amino-1MQ / AOD-9604 / Tesamorelin

Same Instagram “metabolic” shelf. Different jobs.

• SLU — lab-made ERR pan-agonist. Exercise-gene / endurance-fiber / metabolic-syndrome mouse lane.
• MOTS-c — mitochondrial-encoded peptide research map. Different origin story than a lab-made ERR tool. See MOTS-c.
• 5-Amino-1MQ — NNMT-adjacent metabolic research map. Not an ERR on-switch. See 5-Amino-1MQ.
• AOD-9604 — HGH-fragment fat-loss research map with its own human-history baggage. See AOD-9604.
• Tesamorelin — GHRH analogue with a real FDA visceral-fat label in a specific HIV population. Not a research ERR remote. See Tesamorelin.

Why this matters: stacking nicknames is how people buy five bottles for one unanswered question.

So what for you: pick the map that matches the mechanism you actually care about.

Myths that waste money

• “It replaces cardio.” Papers study pieces of an aerobic gene program in mice. They do not erase Zone 2, VO2 work, or recovery.
• “It is just like a GLP-1.” Different dock family. Different evidence. Different risk and access story.
• “ShredMAX is clinically proven weight loss.” Catalog branding is not a Phase 3 obesity trial.
• “If it is in ACS, it is safe for me.” Published chemistry is not a personal safety clearance.
• “More bottles beat better sleep.” Basics still outrank meme chemistry for most readers.

Why this matters: myth stacks are how health pages get people hurt and domains get punished.

So what for you: keep the ERR curiosity. Kill the Marvel script.

Partner research options (codes in the links)

If you are mapping research SKUs after you understand the doors, this is the public InStock SLU partner on this publish pass. Adjacent metabolic research maps sit below. Codes live in the links. Click them so the discount fires.

SLU hero

BioLongevity ShredMAX · LEE15

Adjacent metabolic research maps

MOTS-c · LEE15 5-Amino-1MQ · LEE15 Tesamorelin · LEE15 AOD-9604 · LEE10

Partner home chips when a named product row is out of stock or missing on this pass: Limitless LEE20, Paramount LEE10, Peptira LEE, S1 LEE10, BioLongevity LEE15. Limitless SLU was schema OutOfStock on this pass. The card stays for named Drive row visibility. ShredMAX remains the InStock hero. Paramount had no named SLU Drive product row on this pass. AOD is the adjacent convert. Peptira and S1 had no named SLU Drive product row on this pass.

How to think about next steps

If your real goal is better conditioning, start with Door 3. Zone 2 you can repeat beats a bottle you cannot explain. If your real goal is metabolic disease care, start with Door 2. If your real goal is understanding why SLU keeps showing up in catalogs, Door 1 is fine. Read that door after the ERR map makes sense.

Pro goes deeper on stacks, timing frameworks, and how to read a COA without getting conned. The free page’s job is the map.

Why this matters: next steps that match the door save money and cut health-page risk.

So what for you: write down your actual question in one sentence before you click a code.

Key takeaways (echo)

• SLU is a lab-made ERR pan-agonist with strongest ERRα activity in published chemistry. It is not an FDA exercise pill.
• The best one-line picture is a gym-stereo remote for mitochondrial aerobic gene programs in cell and mouse models.
• Evidence is interesting and preclinical. Basics and doctor care still outrank hype bottles for most readers.

Want the deeper classroom version later? Peptides & Pump Pro is where protocols and stack literacy live.

Sources & Further Reading

• Billon C, et al. Synthetic ERRα/β/γ Agonist Induces an ERRα-Dependent Acute Aerobic Exercise Response and Enhances Exercise Capacity. ACS Chem Biol. 2023. PMID 36988910. PMC PMC11584170.
• Billon C, et al. A Synthetic ERR Agonist Alleviates Metabolic Syndrome. J Pharmacol Exp Ther. 2024. PMID 37739806. PMC PMC10801787.
• Wang XX, et al. Estrogen-Related Receptor Agonism Reverses Mitochondrial Dysfunction and Inflammation in the Aging Kidney. Am J Pathol. 2023. PMID 37717940.
• Xu W, et al. Novel Pan-ERR Agonists Ameliorate Heart Failure Through Enhancing Cardiac Fatty Acid Metabolism and Mitochondrial Function. Circulation. 2024. PMID 37961903.
• An orally active estrogen receptor-related receptor agonist, SLU-PP-915, enhances aerobic exercise capacity. J Pharmacol Exp Ther. 2026. PMID 41421047.
• In Vitro Metabolism and Analytical Characterization of SLU-PP-332 and SLU-PP-915: Novel Pan-ERR Agonists With Doping Potential. Rapid Commun Mass Spectrom. 2026. PMID 41588687.
• Targeting ERRs to counteract age-related muscle atrophy associated with physical inactivity: a pilot study. Front Physiol. 2025. PMID 40692696.
• The Estrogen Receptor-Related Orphan Receptors Regulate Autophagy through TFEB. Mol Pharmacol. 2024. PMID 39168657.

Related reads on this site: MOTS-c, 5-Amino-1MQ, AOD-9604, Tesamorelin, NAD+, Zone 2, peptides for weight loss.

Codes I actually use: LEE20 Limitless · LEE15 BioLongevity · LEE10 Paramount · LEE Peptira · LEE10 S1

Supplier footnote: Research supplier I mention when people ask about SLU-PP-332: BioLongevity ShredMAX (SLU-PP-332) (code LEE15). Named Drive row also exists at Limitless SLU-PP-332 capsules (code LEE20; schema OutOfStock on this pass). Adjacent research maps: BLL MOTS-c, BLL 5-Amino-1MQ, BLL Tesamorelin, BLL NAD+, BLL Metabolic Blend, Paramount AOD-9604. Partner home/shop chips: Limitless (code LEE20), Paramount (code LEE10), Peptira (code LEE), S1 shop (code LEE10), plus BioLongevity home (code LEE15). Match the product to the job. Do not collect bottles.

Affiliate disclosure. Some links on this page are affiliate links. If you buy through them, I may earn a commission at no extra cost to you. Codes LEE15, LEE20, LEE, and LEE10 are the ones I actually use where a coupon fires. That commission is how I keep publishing free education. I only link suppliers I am willing to put my name on.